Clinical Trials List
2019-08-01 - 2025-06-30
Phase II
Recruiting5
Terminated2
ICD-10C22.0
Liver cell carcinoma
ICD-10C22.2
Hepatoblastoma
ICD-10C22.3
Angiosarcoma of liver
ICD-10C22.4
Other sarcomas of liver
ICD-10C22.7
Other specified carcinomas of liver
ICD-10C22.8
Malignant neoplasm of liver, primary, unspecified as to type
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.0
Malignant neoplasm of liver, primary
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ming-Shun Wu NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-I Hsieh NA
- Wei-Yu Kao Digestive System Department
- 夏和雄 NA
- Huey-En Tzeng 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Yu Hsieh NA
- 李宗穎 Digestive System Department
- HUI-WEN LIU NA
- Tsu-Yi Chao 未分科
- Ming-Yao Chen NA
- Wei-Hong Cheng NA
- Ming-Zhe Tay Digestive System Department
- TSU-YI CHAO NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- San-Chi Chen NA
- Rheun-Chuan Lee 未分科
- 姜乃榕 NA
- Yee Chao 未分科
- Chung-Pin Li NA
- Ming-Huang Chen NA
- Yi-Hsiang Huang NA
- I-Cheng Lee NA
- Yi-Ping Hung NA
- Pei-Chang Lee NA
- Chien-An Liu NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiu Hung Chiu NA
- 劉奕廷 NA
- Yih-Jyh Lin NA
- 顏志傑 NA
- 簡世杰 NA
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳庭榕 NA
- 周宏學 NA
- 王瑜肇 NA
- 李兆偉 NA
- Jen-Shi Chen NA
- 吳宗翰 NA
- Wei-Chen Lee NA
- Kun-Ming Chan NA
- 呂嘉偉 NA
- Shi-Ming Lin NA
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 許士超 Division of General Surgery
- Cheng-Yuan Peng Digestive System Department
- Hung-Wei Wang NA
- Hsueh-Chou Lai Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
125 participants
